2Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.PubMed译血液中的神经丝轻链蛋白作为亨廷顿舞蹈病神经退行性变的潜在生物标志物：一项回顾性队列分析
et al.
Lancet Neurol. 2017 Aug;16(8):601-609. doi: 10.1016/S1474-4422(17)30124-2. Epub 2017 Jun 7.
3Mapping neurodegeneration across the Huntington's disease spectrum: a five-year longitudinal analysis of plasma neurofilament light.PubMed译在亨廷顿病谱中绘制神经退行性变图谱：对血浆神经丝轻链的五年纵向分析。
Georgia M Parkin, Elizabeth A Thomas, Jody Corey-Bloom
EBioMedicine. 2024 Jun;104:105173. doi: 10.1016/j.ebiom.2024.105173. Epub 2024 May 29.
4Cortical microstructural correlates of plasma neurofilament light chain in Huntington's disease.PubMed译亨廷顿舞蹈病中血浆神经丝轻链的皮质微结构相关性
5Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression.PubMed译亨廷顿病中的血浆神经丝轻链：疾病起始的标志物，但不是症状进展的标志物。
Georgia M Parkin, Jody Corey-Bloom, Chase Snell, et al.
6Plasma neurofilament heavy chain levels in Huntington's disease.PubMed译亨廷顿舞蹈症患者的血浆神经丝重链水平
et al.
Neurosci Lett. 2007 May 7;417(3):231-3. doi: 10.1016/j.neulet.2007.02.053. Epub 2007 Feb 24.
7Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.PubMed译亨廷顿病青年研究（HD-YAS）中基因携带者的生物学和临床特征：一项横断面分析。
Rachael I Scahill, Paul Zeun, Katherine Osborne-Crowley, et al.
Lancet Neurol. 2020 Jun;19(6):502-512. doi: 10.1016/S1474-4422(20)30143-5. Epub 2020 May 26.
8Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.PubMed译脑脊液和血液中的神经丝轻蛋白与亨廷顿病 R6/2 小鼠的神经退行性变和疾病严重程度相关。
Rana Soylu-Kucharz, Åsa Sandelius, Marie Sjögren, et al.
Sci Rep. 2017 Oct 26;7(1):14114. doi: 10.1038/s41598-017-14179-1.
9Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?PubMed译Tau蛋白还是神经丝轻链——哪种是更适合亨廷顿舞蹈症的生物标志物？
et al.
PLoS One. 2017 Feb 27;12(2):e0172762. doi: 10.1371/journal.pone.0172762. eCollection 2017.
10Neurofilament light protein in blood predicts regional atrophy in Huntington disease.PubMed译血液中的神经丝轻蛋白可预测亨廷顿病的区域性萎缩。
Eileanoir B Johnson, Lauren M Byrne, Sarah Gregory, et al.
Neurology. 2018 Feb 20;90(8):e717-e723. doi: 10.1212/WNL.0000000000005005. Epub 2018 Jan 24.
相关文献
1A 14-year longitudinal study of neurofilament light chain dynamics in premanifest and transitional Huntington's disease.PubMed译一项针对前显型和过渡期亨廷顿病神经丝轻链动态的 14 年纵向研究。
Z J Voysey, N E Owen, J A Holbrook, et al.
J Neurol. 2024 Dec;271(12):7572-7582. doi: 10.1007/s00415-024-12700-x. Epub 2024 Oct 3.
相关文献
1Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional study.PubMed译血浆 NfL 作为一种预后生物标志物，用于丰富 HD-ISS 分期 1 的分类：一项横断面研究。
Georgia M Parkin, Elizabeth A Thomas, Jody Corey-Bloom
EBioMedicine. 2023 Jul;93:104646. doi: 10.1016/j.ebiom.2023.104646. Epub 2023 Jun 12.
2Application Value of Serum Neurofilament Light Protein for Disease Staging in Huntington's Disease.PubMed译血清神经丝轻蛋白在亨廷顿病疾病分期中的应用价值。
Xiao-Yan Li, Yu-Feng Bao, Juan-Juan Xie, et al.
Mov Disord. 2023 Jul;38(7):1307-1315. doi: 10.1002/mds.29430. Epub 2023 May 6.
3A biological classification of Huntington's disease: the Integrated Staging System.PubMed译亨廷顿病的生物学分类：综合分期系统。
Sarah J Tabrizi, Scott Schobel, Emily C Gantman, et al.
4CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.PubMed译CAG 重复序列长度与亨廷顿病发病年龄的关系：统计方法的综述和验证研究。
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen, et al.
Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):397-408. doi: 10.1002/ajmg.b.30992.
5The disparate effects of Alzheimer's disease and Huntington's disease on semantic memory.PubMed译阿尔茨海默病和亨廷顿舞蹈病对语义记忆的不同影响。
